Health
Akeso's Cancer Drug Triumphs Over AstraZeneca's Imfinzi in Phase 3 Trial
By Editor • August 27, 2026 • 1 min read
Akeso's ivonescimab outperformed AstraZeneca's Imfinzi in a phase 3 trial for biliary tract cancer, marking a key achievement for China's biopharmaceutical industry.
Read more